[1] 张华, 杨蓉, 叶贝贝, 等. 389例口腔鳞状细胞癌预后影响因素分析[J]. 天津医科大学学报, 2018, 24(4):315-322. [2] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2015[J]. CA Cancer J Clin, 2015, 65(1):5-29. [3] Wang YF, Ma SR, Wang WM, et al.Inhibition of surviving reduces HIF-1alpha, TGF-betal and TFE3 in salivary adenoid cystic carcinoma[J]. PLoS One, 2014, 9(12):e114015. [4] Zhang L, Zhang W, Wang YF, et al.Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma[J]. Cell Death Dis, 2015, 6:e1771. [5] He KF, Zhang L, Huang CF, et al.CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma[J].Biomed Res Int, 2014:838632. [6] Kurihara-Shimomura, Sasahira T, Shimomura H, et al. The Oncogenic Activity of miR-29b-1-5p Induces the Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma [J].J Clin Med,2019, 8(2). pii:E273. [7] Chen YF, Wei YY, Yang CC, et al.miR-125b suppresses oral oncogenicity by targeting the anti-oxidative gene PRXL2A[J]. Redox Biol, 2019, 22:101140. doi: 10.1016/j.redox.2019.101140.[Epub ahead of print] [8] Ji L, Zhu ZN, He CJ, et al.MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma[J]. Eur Rev Med Pharmacol Sci, 2019, 23(2):630-640. [9] Wei D, Shen B, Wang W, et al. MicroRNA 199a 5p functions as a tumor suppressor in oral squamous cell carcinoma via targeting the IKKβ/NFκB signaling pathway[J]. Int J Mol Med, 2019 Jan 29. doi: 10.3892/ijmm.2019.4083.[Epub ahead of print]. [10] 皇甫冰, 庞文彪, 宋国华, 等. 中国仓鼠口腔颊囊黏膜癌模型的建立及癌变的动态观察[J]. 癌变·畸变·突变, 2016, 28(1):56-65. [11] 李莉红, 庞文彪, 宋国华, 等. 中国仓鼠口腔颊黏膜癌中miRNA与mRNA表达谱的关联分析[J]. 中国实验动物学报, 2018, 26(02):158-164. [12] 常凯, 高继萍, 宋晓娜, 等. miR-34c在口腔鳞状细胞癌的表达及对Tca8113细胞生物学行为的影响[J]. 中国比较医学杂志, 2018, 28(11):15-20. [13] 张宝平. 金黄仓鼠口腔颊囊癌动物模型在重离子放射治疗中的应用[D]. 兰州: 兰州大学, 2011. [14] 葛姝云. 4NQO诱发大鼠舌白斑癌变的实验研究[C]. 上海: 上海第二医科大学口腔医学院、上海市口腔医学会. 中华口腔医学会第六届全国口腔黏膜病学术会议论文集, 2004:1. [15] 高伟. miRNA/miRNA*二级结构影响miRNA169调控靶基因NFYA5方式的研究[D]. 中国农业科学院, 2015. [16] Saunders MA, Liang H, Li WH.Human polymorphism at microRNAs and microRNA target sites[J]. Proc Natl Acad Sci U S A, 2007, 104(9):3300-3305. [17] Duan S, Mi S, Zhang W, et al.Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes[J]. RNA Biol, 2009, 6(4):412-425. [18] Han M, Zheng Y.Comprehensive analysis of single nucleotide polymorphisms in human MicroRNAs[J]. PLoS One, 2013, 8(11):e78028. [19] Cui R, Guan Y, Sun C, et al.A tumor-suppressive microRNA, miR-504, inhibits cell proliferation and promotes apoptosis by targeting FOXP1 in human glioma[J]. Cancer Lett, 2016, 374(1):1-11. [20] Kikkawa N, Kinoshita T, Nohata N, et al.microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma[J]. Int J Oncol, 2014, 44(6):2085-2092. [21] Quan H, Li B, Yang J.MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling[J]. Biomed Pharmacother, 2018, 107:754-762. [22] Ye MF, Zhang JG, Guo TX, et al.MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer[J]. Biomed Pharmacother, 2018, 97:1289-1295. [23] Cai Q, Zeng S, Dai X, et al.miR-504 promotes tumour growth and metastasis in human osteosarcoma by targeting TP53INP1[J]. Oncol Rep, 2017, 38(5):2993-3000. [24] Yang MH, Lin BR, Chang CH, et al.Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling[J]. Oncogene, 2012, 31(19):2401-2411. |